How to manage patients who have reached their weight loss goal on GLP-1 based medications

Dr Paige Lanyon-Roberts

writer

Dr Paige Lanyon-Roberts

General Practitioner, Bariatric Doctor & Surgical Assistant; Medical Director, MedSurg Weight Loss

Claim CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

1 hours

These are activities that use your work data to ensure quality results.

EA
0.5 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 minutes

These are activities that require reflection on feedback about your work.

MO
1 minutes

These are activities that use your work data to ensure quality results.

Patients taking medications for weight loss often ask if they will ever be able to stop or reduce their dose without sacrificing results – but until now, there has not been randomised controlled data to inform the answers.

However, in May, the Lancet published results from SURMOUNT-MAINTAIN1, the first randomised controlled trial to examine whether patients can maintain weight loss and cardiometabolic benefits at a lower dose of an effective obesity medication.

This article summarises the key findings and offers practical guidance on how Australian GPs can apply this evidence in clinical consultations.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

  1. Horn D et al. Lancet. 2026;407:2305–2318.
  2. Aronne LJ et al. JAMA. 2024;331(1):38–48.
  3. Rubino D et al. JAMA. 2021;325(14):1414–25.
  4. West S et al. BMJ. 2026;392:e085304.
  5. Jastreboff AM, et al. N Engl J Med. 2022;387:205–216.
  6. Wilding JPH et al. N Engl J Med. 2021;384:989–1002.
  7. Gilbert O et al. J Am Coll Cardiol. 2025;86(7).

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel – Dr Georgia Rigas & A/Prof Samantha Hocking, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & A/Prof Samantha Hocking, facilitated by Dr Angela Kwong

Weight Management in Women of Reproductive Age

Jarrod Warner & Irene Schneider

Jarrod Warner & Irene Schneider

New Spirometry Standards: Key Changes for Clinical Practice

A/Prof Alberto Pinzon Charry

A/Prof Alberto Pinzon Charry

Food Allergy Prevention

A/Prof Daryl Cheng

A/Prof Daryl Cheng

Protecting Young Lungs – Paediatric Insights into RSV

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.